Table 3 Univariate analysis for potential predictors of terlipressin and concomitant albumin response
Variables | OR (95 % CI) | p |
|---|---|---|
Age | ||
>50 | 2.0 (0.67–5.98) | 0.21 |
≤50 | ||
Gender | ||
Male | 2.9 (0.67–12.9) | 0.15 |
Female | ||
Etiology of cirrhosis | ||
Viral hepatitis | 1.5 (0.49–4.80) | 0.45 |
Others | ||
Child–Pugh score | ||
≤10 | 1.7 (0.57–5.05) | 0.33 |
>10 | ||
Ascites | ||
Yes | 2.2 (0.37–13.63) | 0.36 |
No | ||
Active bacterial infection | ||
Yes | 1.2 (0.38–4.20) | 0.69 |
No | ||
Serum total bilirubin (mg/dl) | ||
≤3 | 2.0 (0.67–5.98) | 0.21 |
>3 | ||
Serum albumin (g/dl) | ||
≥2.8 | 1.51 (0.49–4.57) | 0.46 |
<2.8 | ||
Serum creatinine (mg/dl) | ||
<2.5 | 6.13 (1.47–25.44) | 0.01 |
≥2.5 | ||
Serum Na (mEq/L) | ||
≥130 | 2.45 (0.76–7.88) | 0.13 |
<130 | ||
Urine volume (ml/day) | ||
≥400 | 2.33 (0.76–7.08) | 0.13 |
<400 | ||
MAPa (mmHg) | ||
≥80 | 2.31 (0.77–6.98) | 0.13 |
<80 | ||